Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Myelodysplastic Syndromes 19Lymphoma, Non-Hodgkin 11Hodgkin Disease 10Leukemia, Biphenotypic, Acute 8Multiple Myeloma 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia 7Burkitt Lymphoma 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Myeloproliferative Disorders 6Neuroblastoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Anemia, Refractory, with Excess of Blasts 5Recurrence 4Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hematologic Neoplasms 4Breast Neoplasms 4Medulloblastoma 3Lymphoma, T-Cell 3Lymphoma, Follicular 3Leukemia, Myelomonocytic, Chronic 3Sarcoma 2Rhabdomyosarcoma 2Primary Myelofibrosis 2Neoplasms, Plasma Cell 2Myelodysplastic-Myeloproliferative Diseases 2

Interventions

enzalutamide 94Magnetic Resonance Spectroscopy 85Specimen Handling 66Prednisone 64Androgen Antagonists 59Abiraterone Acetate 58apalutamide 56Radiosurgery 52darolutamide 48Radiotherapy 47Leuprolide 47abiraterone 45Docetaxel 42Pluvicto 32Biopsy 31acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 30Radiation 30relugolix 28Surveys and Questionnaires 28gallium 68 PSMA-11 26Standard of Care 26pembrolizumab 25Goserelin 25Triptorelin Pamoate 24Gonadotropin-Releasing Hormone 23bicalutamide 22Brachytherapy 21Carboplatin 20cabazitaxel 19X-Rays 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Granulocyte Colony-Stimulating Factor × 1 year × Clear all
NCT05011188 2025-08-27

FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer

University of California, San Francisco

Phase 1/2 Active not recruiting
44 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡